Intelligence · Clinical Development
Pipeline search results
Programs matching “doxycycline” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 12 pipeline programs matching "doxycycline" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Doxycycline
United Therapeutics Europe Ltd
Lymphedema
3 trials -
Doxycycline
Hospital Authority, Hong Kong
Tuberculosis
1 trial -
Doxycycline (200mg/day) or Placebo
United Therapeutics Europe Ltd
Persian Gulf Syndrome
1 trial -
Ceftriaxone 1000mg + doxycycline 100 mg
Hong Kong Baptist University
Neisseria Gonorrhoeae Infection
1 trial -
Doxycycline
Hospital Authority, Hong Kong
Tuberculosis, Meningeal
1 trial -
Doxycycline
United Therapeutics Europe Ltd
Advanced Malignant Neoplasm
1 trial -
Doxycycline EG 200 mg Tabletten
The George Institute
Bacterial sexually transmittable diseases (chlamydia, gonorrhea, syphilis)
1 trial -
FDX104 (4% Doxycycline)
VYNE Therapeutics
Rash Due to Epidermal Growth Factor Receptor Inhibitors
1 trial -
Doxycycline Monohydrate
Teva Pharma GmbH
Healthy
2 trials -
Doxycycline
Jian Li
Amyloidosis; Systemic
1 trial -
NanoDOX 1% doxycycline monohydrate Hydrogel
United Therapeutics Europe Ltd
Dehisced Surgical Wounds
1 trial -
Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.